Peter Vaselopulos in Evanston, Illinois

Home Illinois Evanston

Peter Vaselopulos has Urology as his primary medical specialty. Their primary office is: 800 Austin St in Evanston, Illinois. There is an additional office location, for a total of two, for Peter Vaselopulos that can be viewed further down.

They're a part of the: Metro Chicago Surgical Oncology Llc medical group which has around 16 members. You can call their office at 847-328-5600 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 1989 (around 35 years of experience). They are listed as doing telehealth appointments.

Peter T Vaselopulos Office Phone and Directions

Peter Vaselopulos
Metro Chicago Surgical Oncology Llc
800 Austin St
Evanston, Illinois 60202
847-328-5600

Patient Ratings
Please rate your experience with Peter Vaselopulos below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 847-328-5600

Enter a starting address:

Healthcare Info for Peter Vaselopulos

Medical School: Sorry, his university is not listed
Graduation Year: 1989
The Primary Medical Specialty for Peter Vaselopulos is listed as: Urology
Approximate Years of Experience: 35
PAC (PECOS ID)#: 7810092715
NPI #: 1578608949
NPI Created On: 02/21/2007
NPI Last Updated Listed as: 09/11/2012
Primary Taxonomy Code: 208800000X
License Number:
036090702
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Celtic Insurance Company
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Greek, Modern.

Services and Procedures include:

Insertion of needle into vein, patient 3 years or older
Insertion of indwelling bladder catheter
Insertion of indwelling bladder catheter
Insertion of indwelling bladder catheter
Bladder instillation of cancer preventive, inhibiting, or suppressive agent
Ultrasound measurement of bladder capacity after voiding
Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope
Insertion of catheter into urinary duct (ureter) using an endoscope
Destruction of (less than 0.5 centimeters) growths of the bladder and bladder canal (urethra) using an endoscope
Removal of foreign body, stone, or stent from bladder canal (urethra) or bladder using an endoscope
Insertion of stent in urinary duct (ureter) using an endoscope
Destruction of prostate tissue accessed through urethra using radiofrequency generated water vapor heat therapy
Biopsy of prostate gland
Imaging of urinary tract
Ultrasound of rectum
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 45 minutes
Established patient office or other outpatient visit, typically 10 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 754276802

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Urological

Name of Drug #1: Lithostat

Open Associated Drug #1: 0178-0500-01

Payments Total: $85

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405915

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $100

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405919

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405923

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405927

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405931

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405936

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $25

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405939

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405943

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Payments Total: $20

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788405947

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: ERLEADA

Open Associated Drug #1: 59676-600-12

Additional Office Locations

1. Metro Chicago Surgical Oncology Llc
5140 N California Ave
Chicago, IL 60625
Suite 600
Group Members: 16

Phone: 847-328-5600

Enter a starting address:

Urology Professionals in Evanston

1.
Daniel Merrick MD

355 Ridge Ave
Evanston, IL
Uropartners Llc

2.
Mark Schacht

800 Austin St
Evanston, IL
Metro Chicago Surgical Oncology Llc

3.
Matthew Meadows MD

355 Ridge Ave
Evanston, IL
Uropartners Llc

4.
Peter Colegrove MD

2650 Ridge Ave
Evanston, IL
North Shore University Healthsystem Faculty Practice Associates

5.
Peter Colegrove MD

1300 Oak Ave
Evanston, IL
North Shore University Healthsystem Faculty Practice Associates

6.
Peter Colegrove MD

1000 Central St
Evanston, IL
North Shore University Healthsystem Faculty Practice Associates

Providers in Metro Chicago Surgical Oncology Llc

1.Joseph Calandra

3201 Old Glenview Rd
Wilmette Il 60091-2964
Metro Chicago Surgical Oncology Llc
Diagnostic Radiology

2.Allen Chernoff

3201 Old Glenview Rd
Wilmette Il 60091-2964
Metro Chicago Surgical Oncology Llc
Urology

3.Allen Chernoff

3000 N Halsted St
Chicago Il 60657-5196
Metro Chicago Surgical Oncology Llc
Urology

4.Neil Friedman Md

3201 Old Glenview Rd
Wilmette Il 60091-2964
Metro Chicago Surgical Oncology Llc
Urology

5.Fadi Habib Md

5600 W Addison St
Chicago Il 60634-4468
Metro Chicago Surgical Oncology Llc
Urology

6.Fadi Habib Md

331 W Surf St
Chicago Il 60657-7227
Metro Chicago Surgical Oncology Llc
Urology

View all 16 members of Metro Chicago Surgical Oncology Llc medical group